Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
Annexin 1 (ANXA1) was originally identified as a mediator of the anti-inflammatory actions of glucocorticoids (GCs) in the host defense system. Subsequent work confirmed and extended these findings and also showed that the protein fulfills a wider brief and serves as a signaling intermediate in a nu...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1797071235250651136 |
|---|---|
| author | Buckingham, J John, C Solito, E Tierney, T Flower, R Christian, H Morris, J |
| author_facet | Buckingham, J John, C Solito, E Tierney, T Flower, R Christian, H Morris, J |
| author_sort | Buckingham, J |
| collection | OXFORD |
| description | Annexin 1 (ANXA1) was originally identified as a mediator of the anti-inflammatory actions of glucocorticoids (GCs) in the host defense system. Subsequent work confirmed and extended these findings and also showed that the protein fulfills a wider brief and serves as a signaling intermediate in a number of systems. ANXA1 thus contributes to the regulation of processes as diverse as cell migration, cell growth and differentiation, apoptosis, vesicle fusion, lipid metabolism, and cytokine expression. Here we consider the role of ANXA1 in the neuroendocrine system, particularly the hypothalamo-pituitary-adrenocortical (HPA) axis. Evidence is presented that ANXA1 plays a critical role in effecting the negative feedback effects of GCs on the release of corticotrophin (ACTH) and its hypothalamic-releasing hormones and that it is particularly pertinent to the early-onset actions of the steroids that are mediated via a nongenomic mechanism. The paracrine/juxtacrine mode of ANXA1 action is discussed in detail, with particular reference to the significance of the secondary processing of ANXA1, the processes that control the intracellular and transmembrane trafficking of the protein of the molecule and the mechanism of ANXA1 action on its target cells. In addition, the role of ANXA1 in the perinatal programming of the HPA axis is discussed. |
| first_indexed | 2024-03-06T22:50:21Z |
| format | Journal article |
| id | oxford-uuid:5e8fcf40-b61a-4b40-83e4-324fd7d2a81f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:50:21Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:5e8fcf40-b61a-4b40-83e4-324fd7d2a81f2022-03-26T17:41:36ZAnnexin 1, glucocorticoids, and the neuroendocrine-immune interface.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5e8fcf40-b61a-4b40-83e4-324fd7d2a81fEnglishSymplectic Elements at Oxford2006Buckingham, JJohn, CSolito, ETierney, TFlower, RChristian, HMorris, JAnnexin 1 (ANXA1) was originally identified as a mediator of the anti-inflammatory actions of glucocorticoids (GCs) in the host defense system. Subsequent work confirmed and extended these findings and also showed that the protein fulfills a wider brief and serves as a signaling intermediate in a number of systems. ANXA1 thus contributes to the regulation of processes as diverse as cell migration, cell growth and differentiation, apoptosis, vesicle fusion, lipid metabolism, and cytokine expression. Here we consider the role of ANXA1 in the neuroendocrine system, particularly the hypothalamo-pituitary-adrenocortical (HPA) axis. Evidence is presented that ANXA1 plays a critical role in effecting the negative feedback effects of GCs on the release of corticotrophin (ACTH) and its hypothalamic-releasing hormones and that it is particularly pertinent to the early-onset actions of the steroids that are mediated via a nongenomic mechanism. The paracrine/juxtacrine mode of ANXA1 action is discussed in detail, with particular reference to the significance of the secondary processing of ANXA1, the processes that control the intracellular and transmembrane trafficking of the protein of the molecule and the mechanism of ANXA1 action on its target cells. In addition, the role of ANXA1 in the perinatal programming of the HPA axis is discussed. |
| spellingShingle | Buckingham, J John, C Solito, E Tierney, T Flower, R Christian, H Morris, J Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. |
| title | Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. |
| title_full | Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. |
| title_fullStr | Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. |
| title_full_unstemmed | Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. |
| title_short | Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. |
| title_sort | annexin 1 glucocorticoids and the neuroendocrine immune interface |
| work_keys_str_mv | AT buckinghamj annexin1glucocorticoidsandtheneuroendocrineimmuneinterface AT johnc annexin1glucocorticoidsandtheneuroendocrineimmuneinterface AT solitoe annexin1glucocorticoidsandtheneuroendocrineimmuneinterface AT tierneyt annexin1glucocorticoidsandtheneuroendocrineimmuneinterface AT flowerr annexin1glucocorticoidsandtheneuroendocrineimmuneinterface AT christianh annexin1glucocorticoidsandtheneuroendocrineimmuneinterface AT morrisj annexin1glucocorticoidsandtheneuroendocrineimmuneinterface |